Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical management of loiasis in high-transmission regions of Gabon
PACTR202302664171196Phase 3Recruiting
- Sponsor
- Bernhard Nocht Institute for Tropical Medicine
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ivermectin, albendazole and Placebo-COD Research Private Ltd in loiasis (3 arms), sponsored by Bernhard Nocht Institute for Tropical Medicine. Primary endpoint: Superiority in patient-reported outcome measures at month 6. Started Mar 2023; status: recruiting.
02
Drugs
ivermectinalbendazolePlacebo-COD Research Private Ltd
03
Conditions
loiasis
Beyond the preview
Go deeper on PACTR202302664171196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202302664171196.